» Articles » PMID: 34066406

NOD1-Targeted Immunonutrition Approaches: On the Way from Disease to Health

Overview
Journal Biomedicines
Date 2021 Jun 2
PMID 34066406
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Immunonutrition appears as a field with great potential in modern medicine. Since the immune system can trigger serious pathophysiological disorders, it is essential to study and implement a type of nutrition aimed at improving immune system functioning and reinforcing it individually for each patient. In this sense, the nucleotide-binding oligomerization domain-1 (NOD1), one of the members of the pattern recognition receptors (PRRs) family of innate immunity, has been related to numerous pathologies, such as cancer, diabetes, or cardiovascular diseases. NOD1, which is activated by bacterial-derived peptidoglycans, is known to be present in immune cells and to contribute to inflammation and other important pathways, such as fibrosis, upon recognition of its ligands. Since immunonutrition is a significant developing research area with much to discover, we propose NOD1 as a possible target to consider in this field. It is relevant to understand the cellular and molecular mechanisms that modulate the immune system and involve the activation of NOD1 in the context of immunonutrition and associated pathological conditions. Surgical or pharmacological treatments could clearly benefit from the synergy with specific and personalized nutrition that even considers the health status of each subject.

Citing Articles

Current Trend and Outcomes on Immunonutrition in Medical and Surgical Fields: An Updated Perspective.

Koo T, Leong X, Zakaria A Malays J Med Sci. 2025; 31(6):65-76.

PMID: 39830099 PMC: 11740823. DOI: 10.21315/mjms2024.31.6.6.


Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases.

Ferreira C, Vieira P, Sa H, Malva J, Castelo-Branco M, Reis F Front Immunol. 2024; 15:1360065.

PMID: 38558823 PMC: 10978763. DOI: 10.3389/fimmu.2024.1360065.


Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1.

Zhuang J, Zhang L, Zhang S, Zhang Z, Xie T, Zhao W Cell Biosci. 2024; 14(1):32.

PMID: 38462600 PMC: 10926635. DOI: 10.1186/s13578-024-01210-y.


Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health.

Apaza C, Dias M, Garcia Tejedor A, Bosca L, Laparra Llopis J Biomedicines. 2024; 12(2).

PMID: 38397943 PMC: 10886542. DOI: 10.3390/biomedicines12020341.


Growth Regulated Oncogene-α Upregulates TNF-α and COX-2 and Activates NOD1/RIPK2 mediated-MAPK Pathway in Head and Neck Squamous Cell Carcinoma.

Chan L, Tseng Y, Wang H, Chien C, Wu C, Wang L J Cancer. 2023; 14(6):989-1000.

PMID: 37151389 PMC: 10158519. DOI: 10.7150/jca.82300.


References
1.
Heim V, Stafford C, Nachbur U . NOD Signaling and Cell Death. Front Cell Dev Biol. 2019; 7:208. PMC: 6783575. DOI: 10.3389/fcell.2019.00208. View

2.
Denou E, Marcinko K, Surette M, Steinberg G, Schertzer J . High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity. Am J Physiol Endocrinol Metab. 2016; 310(11):E982-93. PMC: 4935139. DOI: 10.1152/ajpendo.00537.2015. View

3.
Zhan Y, Seregin S, Chen J, Chen G . Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production. J Immunol. 2016; 196(12):5121-9. PMC: 4893968. DOI: 10.4049/jimmunol.1501822. View

4.
Kao W, Yang C, Su T, Wang Y, Lo Y, Lin S . The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-κB signaling. Apoptosis. 2014; 20(2):174-95. DOI: 10.1007/s10495-014-1062-4. View

5.
Rakner J, Silva G, Mundal S, Thaning A, Elschot M, Ostrop J . Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies. Placenta. 2021; 105:23-31. DOI: 10.1016/j.placenta.2021.01.014. View